← All Sponsors

SPONSOR

ModernaTX, Inc.

Total Trials

1

Recruiting

1

Phases

Phase 4

Conditions studied: SARS-CoV-2

NCT07266558 Phase 4

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)